Data scientists unveil AI framework to identify new indications for existing drugs
Scientists at Klick Applied Sciences have created an artificial intelligence framework that can rapidly identify new use cases for existing therapeutics, according to findings presented Friday at the NeurIPS conference that could greatly improve the drug repurposing process and transform the pharmaceutical industry.
The team debuted their algorithm, called LOVENet, a Large Optimized Vector Embeddings Network which integrates two cutting-edge AI technologies: large language model (LLM), and structured knowledge graph technology, which mathematically represents the relationships between drugs and diseases to offer a fresh ...














